These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11873057)

  • 41. Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse.
    Yang T; Riehl J; Esteve E; Matthaei KI; Goth S; Allen PD; Pessah IN; Lopez JR
    Anesthesiology; 2006 Dec; 105(6):1164-75. PubMed ID: 17122579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Massive rhabdomyolysis associated with influenza A infection.
    Wakabayashi Y; Nakano T; Kikuno T; Ohwada T; Kikawada R
    Intern Med; 1994 Jul; 33(7):450-3. PubMed ID: 7949648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Preoperative risk assessment of children with Duchenne muscular dystrophy and relevance for anesthesia and intra- and postoperative course].
    Wollinsky KH; Weiss C; Gelowicz-Maurer M; Geiger P; Mehrkens HH; Naumann T
    Med Klin (Munich); 1996 Apr; 91 Suppl 2():34-7. PubMed ID: 8684322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [King syndrome].
    Sano M
    Ryoikibetsu Shokogun Shirizu; 2001; (36):430-2. PubMed ID: 11596430
    [No Abstract]   [Full Text] [Related]  

  • 45. Nonanesthetic malignant hyperthermia.
    Lehmann-Horn F; Klingler W; Jurkat-Rott K
    Anesthesiology; 2011 Nov; 115(5):915-7. PubMed ID: 21878807
    [No Abstract]   [Full Text] [Related]  

  • 46. Difficult diagnosis of malignant hyperthermia during laparoscopic surgery.
    Freiermuth D; Poblete B; Singer M; Konrad CJ; Girard T
    Eur J Anaesthesiol; 2013 Oct; 30(10):635-8. PubMed ID: 23736090
    [No Abstract]   [Full Text] [Related]  

  • 47. The risk of rhabdomyolysis and acute renal failure with the patient in the exaggerated lithotomy position.
    Bildsten SA; Dmochowski RR; Spindel MR; Auman JR
    J Urol; 1994 Dec; 152(6 Pt 1):1970-2. PubMed ID: 7966652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacogenetics and pathophysiology of CACNA1S mutations in malignant hyperthermia.
    Beam TA; Loudermilk EF; Kisor DF
    Physiol Genomics; 2017 Feb; 49(2):81-87. PubMed ID: 28011884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Duchenne muscular dystrophy and malignant hyperthermia: a genetic study of the ryanodine receptor in 47 patients.
    Rohde D; Schmitt HJ; Winterpacht A; Münster T
    Eur J Anaesthesiol; 2014 Jun; 31(6):341-2. PubMed ID: 24557023
    [No Abstract]   [Full Text] [Related]  

  • 50. Confirmation of nonanesthetic-induced malignant hyperthermia.
    Larach MG; Allen GC; Rosenberg H
    Anesthesiology; 2012 Jun; 116(6):1398-9; author reply 1399-400. PubMed ID: 22617205
    [No Abstract]   [Full Text] [Related]  

  • 51. Identification of a novel mutation in the ryanodine receptor gene (RYR1) in patients with malignant hyperthermia.
    Rueffert H; Kraus H; Olthoff D; Deutrich C; Froster UG
    Hum Mutat; 2001 Mar; 17(3):238. PubMed ID: 11241852
    [No Abstract]   [Full Text] [Related]  

  • 52. Rhabdomyolysis after infection and taking a cold medicine in a patient who was susceptible to malignant hyperthermia.
    Kasamatsu Y; Osada M; Ashida K; Azukari K; Yoshioka K; Ohsawa A
    Intern Med; 1998 Feb; 37(2):169-73. PubMed ID: 9550599
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Malignant hyperthermia and excitation-contraction coupling.
    Melzer W; Dietze B
    Acta Physiol Scand; 2001 Mar; 171(3):367-78. PubMed ID: 11412150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The biochemistry of malignant hyperthermia: recent concepts.
    Joffe M; Savage N; Silove M
    Int J Biochem; 1992 Mar; 24(3):387-98. PubMed ID: 1312953
    [No Abstract]   [Full Text] [Related]  

  • 55. XXIVth Annual Meeting of the European Malignant Hyperthermia Group.
    Brandom BW; Muldoon SM
    Anesthesiology; 2005 Dec; 103(6):1324. PubMed ID: 16306761
    [No Abstract]   [Full Text] [Related]  

  • 56. Malignant hyperthermia causing Gly2435Arg mutation of the ryanodine receptor facilitates ryanodine-induced calcium release in myotubes.
    Brinkmeier H; Krämer J; Krämer R; Iaizzo PA; Baur C; Lehmann-Horn F; Rüdel R
    Br J Anaesth; 1999 Dec; 83(6):855-61. PubMed ID: 10700782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Autopsied case of Parkinson disease with neuroleptic malignant-like syndrome and rhabdomyolysis].
    Akai M; Ishizaki T; Idemura Y; Sasaki F; Nakai T; Miyaho S; Matsubara R; Uchiki H; Nakaguki K
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1863-4. PubMed ID: 1479229
    [No Abstract]   [Full Text] [Related]  

  • 58. Novel mutation in the RYR1 gene (R2454C) in a patient with malignant hyperthermia.
    Gencik M; Gencik A; Mortier W; Epplen JT
    Hum Mutat; 2000 Jan; 15(1):122. PubMed ID: 10612851
    [No Abstract]   [Full Text] [Related]  

  • 59. Continued progress in understanding the molecular genetics of malignant hyperthermia.
    Rosenberg H
    Can J Anaesth; 2011 Jun; 58(6):489-93. PubMed ID: 21455644
    [No Abstract]   [Full Text] [Related]  

  • 60. A rare genetic variant of the ryanodine receptor in a suspected malignant hyperthermia susceptible patient.
    MacKay EJ; Wilkerson C; Kraeva N; Rosenberg H; Kennedy T
    J Clin Anesth; 2016 Sep; 33():144-6. PubMed ID: 27555149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.